Mantle Cell Lymphoma
News
Gloom lifting as MCL treatments evolve
A rare blood cancer remains incurable, yet new therapies have yielded improved prognoses and survival rates.
News
FDA approved acalabrutinib tablet for MCL, CLL, SLL
Acalabrutinib (Calquence) in tablet formulation approved by FDA.
News
‘Plethora’ of new MCL treatment options
New and potential treatments have emerged for relapsed/refractory mantle cell lymphoma (R/RMCL), a rare but steadily increasing form of non-...
News
Noted oncologist ponders death, life, care inequities
A photojournalist-turned-physician practiced in India and the United Kingdom before rising to prominence in U.S. community oncology.
News
First drug therapy approved for childhood GVHD
FDA greenlights ibrutinib for child blood cancer patients with chronic graft-versus-host disease.
News
Phase 3 data: Zanubrutinib bests standard CLL treatment
Results could spur FDA approval as frontline therapy.
News
Drug shortages plague hematology, but preparedness helps
The plight of desperate patients is getting attention – and some remedies.
Conference Coverage
'New benchmark' set in phase-3 blood cancer study
Phase 3 SHINE study of older patients with mantle cell lymphoma yields “profound” results with ibrutinib add-on.
News
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
News
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”